6.22 (0.22%)
As of Aug 19, 2022
Source:
We are dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. GIAPREZA(angiotensin II) injection is approved by theU.S. Food and Drug Administration (FDA)as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA(eravacycline) for injection is approved by the FDA as a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections (cIAI) in patients 18 years of age and older.
| Country | United States |
| Headquarters | waltham, massachusetts |
| Phone Number | 617-715-3600 |
| Industry | manufacturing |
| CEO | Larry Edwards |
| Website | ljpc.com |